ACH

Business Context and Reporting Period

This summary covers the Form 10-Q for Owens & Minor, Inc. (O&M), a medical supply distributor, for the quarterly period ended June 30, 2007. The company operates primarily in acute-care medical and surgical supply distribution and direct-to-consumer (DTC) distribution. The reporting period includes the impact of the September 2006 acquisition of the acute-care business from McKesson Medical-Surgical Inc., which contributed significantly to revenue growth.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 29.1% in Q2 and 31.3% YTD compared to 2006. Approximately 70% of this increase is attributed to the acquired McKesson business.
• Profitability: Net income improved significantly in Q2 2007 ($18.3M) compared to Q2 2006 ($10.5M). The 2006 period included an $11.4 million pre-tax charge for the early extinguishment of debt, which is not present in 2007.
• Margin Compression: Gross margin percentages declined slightly (10.5% in Q2 2007 vs. 10.9% in Q2 2006) due to contract renewals with group purchasing organizations and volume-based pricing.
• Operating Expenses: SG&A expenses as a percentage of revenue improved in Q2 (7.9%) but were higher YTD (8.2%) due to integration costs for the McKesson acquisition, including $7 million in transition service fees.
• Debt Reduction: The company reduced long-term debt by approximately $64 million during the first half of 2007, utilizing strong operating cash flows to pay down its revolving credit facility.

Outlook, Risks, and Contingencies

• Acquisition Integration: The company has completed the transition of the McKesson business. Management expects continued improvements in asset management (DSO and inventory turnover) and operating earnings as integration costs subside.
• DTC Segment: The Direct-to-Consumer business showed strong growth, with revenue up 31.6% YTD and operating earnings turning positive ($1.3M YTD 2007 vs. $0.0M YTD 2006).
• IRS Dispute (Material Contingency): The IRS has proposed disallowing certain LIFO inventory valuation deductions since 2001. If unsuccessful in its appeal, the company faces a potential tax deficiency of approximately $71.5 million plus interest of $11.9 million. No reserve has been established for this amount.
• Liquidity: The company maintains a $350 million revolving credit facility with $167.6 million available as of June 30, 2007. Management believes this is sufficient for working capital and strategic growth.
• Risk Factors: Key risks include dependence on major customers and suppliers, changes in healthcare reimbursement guidelines (Medicare/Medicaid), and the ability to manage financing costs.

Investor Verification Checklist

• Verify the status and potential outcome of the IRS LIFO inventory dispute, which could result in a $71.5 million tax liability.
• Monitor the gross margin trends as the company integrates the McKesson business and renegotiates contracts with group purchasing organizations.
• Assess the sustainability of operating cash flow improvements, which were driven by reductions in accounts receivable and inventory.
• Review the allowance for doubtful accounts, which increased by $5.3 million YTD, largely related to customers from the acquired McKesson business.
• Track the Direct-to-Consumer (DTC) segment's ability to maintain improved operating earnings following management and facility consolidation.